Form D · Biotechnology
AI3 Bio, Inc.
Watertown, MA · CIK 0002019875
Offering snapshot reported Nov 4, 2026 · SEC filing
- Reported sold
- $48.3M Offering amount: $48.3M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 9, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2026 | Initial | $48,339,490 | No comparison | 8 | SEC filing |
| Nov 4, 2026 | Initial | $0 | No comparison | 7 | SEC filing |
| Oct 20, 2025 | Initial | $16,754,446 | No comparison | 4 | SEC filing |
| Aug 11, 2025 | Amendment | $58,510,656 | No comparison | 14 | SEC filing |
| Apr 30, 2025 | Amendment | $53,441,210 | $2,500,000vs Apr 23, 2024 | 14 | SEC filing |
| Apr 23, 2024 | Initial | $50,941,210 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-603654
Source: Form D, filed Nov 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steve Altschuler | Director, Executive |
| Steven Altschuler | Director, Executive |
| Andrew Bellinger | Director |
| Andrew Cornforth | Executive |
| Jeanne Cunicelli | Director |
| Alan Ezekowitz | Director |
| Nichols Garrett | Executive |
| Jonathan Kagan | Executive |
| Jeffrey Karp | Executive |
| Michael Lyman | Executive |
| Richard Malley | Director |
| Garrett Nichols | Executive |
| Nick Seaver | Director, Executive |
| Fabian Tenenbaum | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
99 Coolidge Ave, Suite 201
Watertown, MA, 02472
Watertown, MA, 02472